- Home
- Publications
- Publication Search
- Publication Details
Title
Antidementia Medication Use in Nursing Home Residents
Authors
Keywords
-
Journal
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-09-16
DOI
10.1177/08919887231202948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative safety and efficacy of cognitive enhancers for Alzheimer’s dementia: a systematic review with individual patient data network meta-analysis
- (2022) Areti Angeliki Veroniki et al. BMJ Open
- Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia
- (2022) Marco Zuin et al. Scientific Reports
- Effectiveness of Treatments for People Living with Severe Dementia: A Systematic Review and Meta-Analysis of Randomised Controlled Clinical Trials
- (2022) Elena Profyri et al. AGEING RESEARCH REVIEWS
- Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium
- (2022) Ori J. Lieberman et al. Alzheimers & Dementia
- Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia: A Systematic Review of Randomized and Nonrandomized Trials
- (2022) Céline Truong et al. NEUROLOGY
- Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
- (2021) Hong Xu et al. NEUROLOGY
- Validation of Claims Algorithms to Identify Alzheimer’s Disease and Related Dementias
- (2021) Ellen P McCarthy et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing
- (2020) Joshua D. Niznik et al. Alzheimers & Dementia
- Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis
- (2020) Domenica Disalvo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan
- (2020) Laura C. Maclagan et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis
- (2020) Tingting Zhang et al. Frontiers in Pharmacology
- Psychosis in Alzheimer’s Disease
- (2020) Clive Ballard et al. Current Neurology and Neuroscience Reports
- Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
- (2020) Jiaxun Guo et al. Brain and Behavior
- Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary
- (2019) Emily Reeve et al. MEDICAL JOURNAL OF AUSTRALIA
- The effect of antidementia drugs on mortality in patients with Alzheimer’s disease
- (2019) Wei-Hao Lin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
- (2019) Dan-Dan Li et al. Frontiers in Neuroscience
- Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia
- (2019) Joshua D. Niznik et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia
- (2019) Joshua D. Niznik et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia
- (2018) Brenna N. Renn et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
- (2018) Ruth Knight et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The efficacy and safety of memantine for the treatment of Alzheimer’s disease
- (2018) Shinji Matsunaga et al. Expert Opinion On Drug Safety
- Memantine is Associated with Longer Survival than Donepezil in a Veterans Affairs Prescription Database, 1997 to 2008
- (2018) Laura C. Lazzeroni et al. JOURNAL OF ALZHEIMERS DISEASE
- Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission
- (2018) Laura C. Maclagan et al. Journal of the American Medical Directors Association
- Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials
- (2018) Kai-Xin Dou et al. Alzheimers Research & Therapy
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
- (2017) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Minimum Data Set 3.0 Cognitive Function Scale
- (2017) Kali S. Thomas et al. MEDICAL CARE
- Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies
- (2016) Jeffrey Cummings et al. CNS Neuroscience & Therapeutics
- Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
- (2016) Daniela Koller et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
- (2015) William James Deardorff et al. DRUGS & AGING
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence
- (2015) Jacob S. Buckley et al. DRUGS & AGING
- Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer’s Disease
- (2015) Jordana O’Regan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
- (2015) Alireza Atri et al. Alzheimers Research & Therapy
- World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care
- (2014) Ralf Ihl et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia
- (2013) Martin R. Farlow et al. CNS Neuroscience & Therapeutics
- Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
- (2012) Serge Gauthier et al. Alzheimers & Dementia
- Guidelines for the Management of Cognitive and Behavioral Problems in Dementia
- (2012) C. H. Sadowsky et al. Journal of the American Board of Family Medicine
- Cholinesterase Inhibitor and Memantine Use in Newly Admitted Nursing Home Residents with Dementia
- (2011) Carole Parsons et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inappropriate Drug Prescription at Nursing Home Admission
- (2011) Fermín García-Gollarte et al. Journal of the American Medical Directors Association
- Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
- (2010) John T O’Brien et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Memantine Discontinuation and the Health Status of Nursing Home Residents With Alzheimer's Disease
- (2010) Howard Fillit et al. Journal of the American Medical Directors Association
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia
- (2009) Lori A. Daiello et al. American Journal Geriatric Pharmacotherapy
- Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence
- (2009) I.A. Lockhart et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors
- (2009) Joseph W. Shega et al. JOURNAL OF PALLIATIVE MEDICINE
- Cholinesterase Inhibitor Use in U.S. Nursing Homes: Results from the National Nursing Home Survey
- (2009) Dallas P. Seitz et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial
- (2008) Akira Homma et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The Aggressive Behavior Scale: A New Scale to Measure Aggression Based on the Minimum Data Set
- (2008) Christopher M. Perlman et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started